<!doctype html>
<html lang="en">

<head>
  <meta charset="UTF-8" />
  <link rel="icon" type="image/svg+xml" href="/vite.svg" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Bloomsbury Burger Therapeutics — The Target is Found</title>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link
    href="https://fonts.googleapis.com/css2?family=Syne:wght@400;600;700;800&family=DM+Mono:ital,wght@0,400;0,500;1,400&family=DM+Sans:ital,wght@0,300;0,400;0,500;1,300&display=swap"
    rel="stylesheet">
</head>

<body>
  <!-- Persistent 3D Background -->
  <div id="canvas-container"></div>

  <!-- Foreground UI -->
  <div class="layout">

    <nav class="navbar">
      <div class="nav-logo">
        <div>
          <div class="wordmark"><span>BBT</span></div>
          <div class="sub">Bloomsbury Burger Therapeutics</div>
        </div>
      </div>
      <div class="nav-links">
        <a href="#problem" class="nav-item">The Problem</a>
        <a href="#approach" class="nav-item">The Method</a>
        <a href="#platform" class="nav-item">The Result</a>
      </div>
      <div class="nav-actions">
        <a href="/dashboard/index.html" class="btn-primary">
          Lab Console →
        </a>
      </div>
    </nav>

    <main class="main-content">

      <!-- ═══════════════════════════════════
                 HERO
            ════════════════════════════════════ -->
      <section class="hero-section" id="hero">
        <div class="hero-content">
          <div class="hero-badge fade-up">
            CAR-T · Endometriosis · Differentiable Discovery
          </div>
          <h1 class="fade-up delay-1">
            The Target<br><span>is Found.</span>
          </h1>
          <p class="hero-stat fade-up delay-2">
            <strong>~4.5M</strong> candidate pairs screened in silico.
            <strong>Two</strong> survived.
          </p>
          <p class="hero-desc fade-up delay-2">
            Dual-target CAR-T therapy for endometriosis,
            discovered by gradient descent over single-cell genomics.
            Not hormone modulation. Not symptom management.
            Targeted cellular ablation of ectopic lesions.
          </p>
          <div class="hero-actions fade-up delay-3">
            <a href="#problem" class="btn-outline">Explore the Architecture ↓</a>
          </div>
        </div>
      </section>

      <!-- ═══════════════════════════════════
                 THE PROBLEM
            ════════════════════════════════════ -->
      <section class="content-section" id="problem">
        <div class="section-text">
          <div class="section-badge">The Standard of Care</div>
          <h2>Blind Resection<br>is Not Enough</h2>
          <div class="text-block">
            <p>
              Endometriosis affects ~10% of people with a uterus worldwide.
              The current standard of care is surgical resection — cutting out
              the lesions — which has a recurrence rate above 50% within five years.
            </p>
            <p>
              Surgeons cannot reliably distinguish all pathological microscopic
              tissue from healthy tissue by visual inspection. The lesions hide.
              The problem is not surgical skill. It is the structural imprecision
              of a therapy that cannot identify what it is targeting at the
              cellular level.
            </p>
            <p>
              A therapy that targets cells directly — not anatomy — does not have
              this problem.
            </p>
          </div>
          <div class="stat-block">
            <div class="stat-card">
              <div class="stat-value">50%</div>
              <div class="stat-label">Post-Surgical Recurrence</div>
              <div class="stat-desc">
                Within 5 years, due to missed microscopic deposits
                and incomplete lesion mapping.
              </div>
            </div>
          </div>
        </div>
        <div class="section-visual" id="dynamic-cards-container">
          <!-- Gene pair cards injected by JS -->
        </div>
      </section>

      <!-- ═══════════════════════════════════
                 THE METHOD
            ════════════════════════════════════ -->
      <section class="content-section right" id="approach">
        <div class="section-text">
          <div class="section-badge">Technical Pipeline</div>
          <h2>We Did Not Enumerate.<br>We Optimised.</h2>
          <div class="text-block">
            <p>
              Brute-force enumeration of dual-target combinations across the
              human transcriptome produces approximately 4.5 million candidate
              pairs. Evaluating each against a whole-body safety atlas is
              computationally intractable.
            </p>
            <p>
              Instead, we relax the discrete combinatorial search into continuous
              space using a <strong>Gumbel-Softmax reparameterisation</strong>.
              We optimise with gradient descent, then snap back to a hard discrete
              selection — combining a biomedical specificity objective with a
              whole-body safety penalty in a jointly differentiable system.
            </p>
            <p>
              The compiler finds the pair. The atlas validates it.
              The result is not a ranked list — it is a proof.
            </p>
          </div>
          <div class="math-block">
            <div class="math-header">Optimization Objective</div>
            <code>min[ L_spec(θ) + λ · L_safe(θ) ]</code>
            <div class="math-footer">Gradient descent active</div>
          </div>

          <!-- DIFFERENTIABLE COMPILER — inline, not fixed -->
          <div class="compiler-panel" id="machine-panel">
            <div class="compiler-titlebar">
              <div class="compiler-dots">
                <span class="dot-red"></span>
                <span class="dot-yellow"></span>
                <span class="dot-green"></span>
              </div>
              <div class="compiler-title">DIFFERENTIABLE COMPILER v0.1</div>
            </div>
            <div class="compiler-body">
              <div class="prob-dists">
                <div class="dist">
                  <span>α¹ — Target A</span>
                  <div class="bars" id="bars-a"></div>
                </div>
                <div class="dist">
                  <span>α² — Target B</span>
                  <div class="bars" id="bars-b"></div>
                </div>
              </div>
              <div class="loss-chart" id="loss-chart-container">
                <svg viewBox="0 0 100 44" preserveAspectRatio="none">
                  <path id="loss-line" d="M0,10 Q25,10 50,28 T100,42" fill="none" stroke="#ff4d6d" stroke-width="1.5" />
                </svg>
              </div>
              <div class="temp-gauge">
                <span class="tau">τ</span>
                <div class="gauge-track">
                  <div class="gauge-fill" id="temp-fill"></div>
                </div>
                <span>annealing</span>
              </div>
            </div>
            <div class="compiler-footer">Gradient descent active · Tabula Sapiens validation enabled</div>
          </div>
        </div>
      </section>

      <!-- ═══════════════════════════════════
                 THE RESULT
            ════════════════════════════════════ -->
      <section class="content-section" id="platform">
        <div class="section-text">
          <div class="section-badge">The Platform</div>
          <h2>Two Targets.<br>Validated Against<br>475 Cell Types.</h2>
          <div class="text-block">
            <p>
              The result is not just a list of markers. It is a
              <strong>safety certificate</strong> validated against the whole
              human body via the Tabula Sapiens single-cell atlas.
            </p>
            <p>
              If a candidate pair is expressed in critical organs — heart,
              brain, kidney — it receives an infinite penalty and is excluded.
              What survives is the blueprint for a truly lesion-specific
              dual-target CAR-T.
            </p>
            <p>
              The top-ranked pairs are shown here. These are real outputs
              from the optimisation run.
            </p>
          </div>
          <div class="cards-preview" id="dynamic-cards-container-2"></div>
        </div>
      </section>

      <!-- ═══════════════════════════════════
                 THE VISION — VISION
            ════════════════════════════════════ -->
      <section class="content-section right" id="vision">
        <div class="section-text">
          <div class="section-badge">What Comes Next</div>
          <h2>From Algorithm<br>to Therapy.</h2>
          <div class="text-block">
            <p>
              We have a computationally validated dual-target pair, a
              differentiable discovery pipeline that can be rerun on any
              disease with single-cell data, and a safety framework validated
              against the most comprehensive human cell atlas available.
            </p>
            <p>
              The next steps are pre-clinical validation of CAR construct
              binding, in vitro ectopic lesion models, and IND-enabling studies.
            </p>
            <p>
              We are pre-seed. If you are a scientist, investor, or collaborator
              who wants to understand the platform in depth, the Lab Console
              has the full data.
            </p>
          </div>
          <div class="hero-actions" style="margin-top: 32px;">
            <a href="/dashboard/index.html" class="btn-primary"
              style="font-size:14px; padding:12px 24px; border-radius:6px;">
              Open Lab Console →
            </a>
          </div>
        </div>
      </section>

      <footer class="site-footer">
        <div class="footer-content">
          <span>Bloomsbury Burger Therapeutics plc © 2026</span>
          <span>pre-seed · pre-revenue · pre-sanity</span>
        </div>
      </footer>

    </main>
  </div>

  <!-- Sound toggle — icon only -->
  <div class="sound-toggle" id="sound-toggle" title="Toggle sound">
    <svg id="sound-icon-on" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
      <path d="M3 9v6h4l5 5V4L7 9H3zm13.5 3c0-1.77-1.02-3.29-2.5-4.03v8.05c1.48-.73 2.5-2.25 2.5-4.02z" />
    </svg>
    <svg id="sound-icon-off" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg" style="display:none">
      <path
        d="M16.5 12c0-1.77-1.02-3.29-2.5-4.03v2.21l2.45 2.45c.03-.2.05-.41.05-.63zm2.5 0c0 .94-.2 1.82-.54 2.64l1.51 1.51C20.63 14.91 21 13.5 21 12c0-4.28-2.99-7.86-7-8.77v2.06c2.89.86 5 3.54 5 6.71zM4.27 3L3 4.27 7.73 9H3v6h4l5 5v-6.73l4.25 4.25c-.67.52-1.42.93-2.25 1.18v2.06c1.38-.31 2.63-.95 3.69-1.81L19.73 21 21 19.73l-9-9L4.27 3zM12 4L9.91 6.09 12 8.18V4z" />
    </svg>
  </div>

  <script type="module" src="/src/main.js"></script>
</body>

</html>